Prevention of Hepatitis B Virus Vertical Transmission Using Hepatitis B Immunoglobulin in the Third Trimester of Pregnancy

Ming-jiao HE,xiao-min XIAO,Yu-yuan XU,Li-luan Xi,Shao-xian HUANG,Li-hong CHEN,Lan-ying LAN

DOI: https://doi.org/10.3969/j.issn.1008-1836.2008.03.008

2008-01-01

Abstract:Objective:To explore the efficacy of hepatitis B immunoglobulin(HBIG) used during the third trimester of pregnancy to prevent vertical transmission of HBV.Methods:A cohort of HbsAg-positive mothers with or without positive HBeAg were assigned to Group A(HBsAg positive and HBeAg-positive,or "dual positive") and Group B(HBsAg positive and HBeAg-negative,or "single positive"),while their newborns were assigned to the HBIG Group and Non-HBIG Group according to their mothers’ use of HBIG.At the 28th,32th,and 36th weeks of pregnancy,mothers of the HBIG group received 200 IU of HBIG Group(three shots required,but not completed in some during the pregnancy).Venous blood of all infants was collected for test of serological HBV markers during their 1st day and 6th month of age.Results:①Significantly,more women in the Group A were found to have positive HBV-DNA(76.92%),compared with those in Group B(8.55%),P<0.01;②Of mothers in Group A,infants assigned to HBIG group showed significantly lower rate of positive HBsAg(10.64%) at 24 hours after birth,compared with those assigned to the non-HBIG group(33.33%),P<0.01;③Six months later,HBIG-treated infants of Group A(Group B) mothers showed a 78.72%(80.65%) rate of HBsAb seroconversion,compared with 38.39%(64.41%) among non-HBIG-treated infants,P<0.05.Conclusion:Administration of HBIG in the third trimester of pregnancy appeared effective in protecting newborns of HBeAg-positive HBV carried from intrauterine HBV infection.For infants of both HBeAg-positive or negative mothers,HbsAb seroconversion at 6 months of age can be raised with late pregnancy use of HBIG.